Clin2
NCT07267481Possibly a fitNot yet recruiting

Switching from Xiidra to a new dry eye drop

Dry EyeDry Eyes ChronicDry Eye SyndromesEye Diseases

Treatments studied

Part of Eyes & vision clinical trials.

This study tests if switching from Xiidra to another dry eye drop (TRYPTYR) works better for people with dry eye disease. You may qualify if Xiidra isn't helping enough and you've been using it for at least a month.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
100 people
Ages
18 years to 99 years
Study type
Interventional

Who can take part

  • 18 years or older
  • Had dry eye disease for at least 6 months
  • Currently using Xiidra eye drops every day for at least 1 month
  • Still having dry eye symptoms (like dryness, burning, or grittiness)
  • Willing to stop wearing contact lenses 24 hours before visits and during the study

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07267299Not yet recruiting· Phase 4
Switching from Restasis to a new dry eye drop, TRYPTYR

This study tests a new dry eye drop called TRYPTYR for people who have been using Restasis but are not satisfied with it. If you qualify, you would stop Restasis and try TRYPTYR to see if it works better for your symptoms.

NCT07266948Recruiting· Phase 4
How TRYPTYR eye drops affect dry eye symptoms and daily life

This study tests a new eye drop called TRYPTYR to see if it can improve quality of life and daily tasks for people with dry eye disease who are unhappy with their current treatment, Restasis. Participants will stop using Restasis and switch to TRYPTYR for about 4 weeks.

Pittsburg, Kansas
NCT07625124Not yet recruiting· Phase 2
Testing a new eye drop for dry eye disease

This study tests whether RCI001, a new eye drop treatment, can help people with dry eye disease. If you've had dry eye symptoms for at least 6 months and are interested in trying a new treatment, this trial may be for you.

NCT07659626Recruiting
Long-term effects of Acoltremon for dry eye disease

This study tests a new medication called Acoltremon to see if it helps dry eye symptoms over a long period. If you've had dry eye for a while and used artificial tears, this trial might be for you.

Louisville, Kentucky
NCT07560735Not yet recruiting· Phase 4
Lifitegrast eye drops for dry eye disease evaluation

This study tests whether lifitegrast eye drops (a medication that reduces eye inflammation) help people with moderate to severe dry eye disease. Researchers will use a special microscope to examine your eye surface before and after treatment.

Nashville, Tennessee
NCT07490535Not yet recruiting· Phase 4
Xiidra eye drops effect on tear markers in dry eye

This study looks at how Xiidra eye drops affect natural tear markers in people with dry eye. It also compares them to a small group of people without dry eye. If you have moderate dry eye and are already using Xiidra (or you do not have dry eye and want to help as a volunteer), you may be able to join.

Sewickley, Pennsylvania

Hear when a new Dry Eye trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.